Search for: "Zhang Feng" Results 21 - 40 of 78
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Mar 2019, 3:39 pm by Sabrina I. Pacifici
Nature [no fee or paywall]: Adopt a moratorium on heritable genome editing, Eric Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven countries call for an international governance framework. [read post]
9 Nov 2018, 6:03 am
Stanfield (UNSW Business School), and Feng Zhang (University of Utah), on Monday, November 5, 2018 Tags: Acquisitions, Buyouts, Conflicts of interest, Controlling shareholders, Fair values, Firm valuation, Freezeouts, Inside information, Investor protection, Management, Market timing, Target firms Bouncing Back from a Low Say-On-Pay Vote Posted by Edward A. [read post]
5 Nov 2018, 6:02 am
Stanfield is Senior Lecturer at UNSW Australia Business School; and Feng Zhang is Assistant Professor at the University of Utah. [read post]
10 Sep 2018, 12:55 pm by Tom Smith
The decision casts a pall over the university’s future earnings from a transformative technique devised by UC Berkeley cell biologist Jennifer Doudna — but improved upon by Feng Zhang of the Broad Institute. [read post]
21 May 2018, 6:35 pm
(Pix © Larry Catá Backer 2006)I am delighted to be part of the upcoming workshop entitled Entangled Legalities hosted by  the Graduate Institute of Geneva and its Global Governance Center (more HERE). [read post]
1 May 2018, 6:50 am by Lisa Ouellette
In late 2012, Feng Zhang of the Broad Institute successfully performed those experiments in human cells and filed for patents covering his iteration of the technology.Zhang’s filings—all of which matured into issued patents—ultimately triggered a patent interference between UC and the Broad Institute, with the UC’s patent application still-to-be issued. [read post]
29 Apr 2018, 11:18 pm by Lawrence B. Ebert
The Broad and Feng Zhang hold a primary patent for CRISPR's use in human cells in the U.S. but no technology is developed in a vacuum. [read post]
12 Mar 2018, 1:37 pm
I am happy to announce the publication of "Between the Judge and the Law: Judicial Independence and Authority With Chinese Characteristics," which appears in the latest issue of the Connecticut Journal of International Law 33(1):1-41 (2017). [read post]
19 Jan 2018, 9:58 am by Lawrence B. Ebert
If Feng Zhang were an inventor on the Marraffnni application, a signed oath by Feng pursuant to 37 CFR 1.63 would have been required. [read post]
13 Jan 2018, 8:51 pm by Patent Docs
Diner and Carla Mouta-Bellum of Finnegan Henderson Farabow Garrett & Dunner, Amy Feng of Wu Feng & Zhang, and Hazel Ford of Finnegan Europe will provide guidance to patent counsel on overcoming the challenges of obviousness in biologics patent claims in the U.S., Europe, and China; will examine the similarities and differences between claim types that have the best chance of success; and will discuss recent case... [read post]
12 Dec 2017, 4:36 pm by Kevin LaCroix
John Reed Stark One of the most interesting and arresting business stories of 2017 has been the astonishing proliferation of initial coin offerings (ICOs), as I discussed in a prior post (here). [read post]
16 Jun 2017, 6:27 am by Jimmy Chalk, Sarah Grant
Feng Zhang, a Fellow at the Australian National University and Adjunct Professor at the National Institute for South China Sea Studies in China, ponders what China can do to take advantage of the uncertainty the Trump Administration has caused regarding the United States’ commitment to its defense alliances. [read post]
On one side is “UC” (a party comprising the University of California, Jennifer Doudna, University of Vienna, and Emmanuelle Charpentier), and on the other side is the “Broad Institute” (a party comprising the Broad Institute, Feng Zhang, MIT, and Harvard). [read post]
23 Apr 2017, 3:09 pm by Lawrence B. Ebert
In a response filed 1 Dec. 2014, applicant was especially harsh to the Doudna application: "Doudna is nothing more than a mere 'second comer' and had no CRISPR-Cas invention prior to Feng Zhang. [read post]
13 Apr 2017, 6:22 am by Lawrence B. Ebert
The Scientist noted on April 13, 2017:Update (April 13): The University of California, Berkeley, has filed an appeal with the US Court of Appeals for the Federal Circuit in Washington, DC, challenging the February ruling of the US Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB), which determined that the patent issued in 2014 for Feng Zhang and colleagues’ work on CRISPR gene-editing technology at the Broad Institute of MIT and Harvard does not… [read post]